Cargando…
Anti-HPV16 oncoproteins siRNA therapy for cervical cancer using a novel transdermal peptide PKU12
In this study, an innovative transdermal peptide, #PKU12, was developed based on transdermal peptide TD-1, and the anti-tumor effect of PKU12-based siRNA against HPV was investigated in vivo. Furthermore, transcriptome differences between PKU12 + siRNA treatment and control groups were compared to a...
Autores principales: | Deng, Yan, Song, Yi, Du, Quan, Wang, Chi Chiu, Li, Hu, Sui, Yi, Zhang, Yuying, Tang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282752/ https://www.ncbi.nlm.nih.gov/pubmed/37350944 http://dx.doi.org/10.3389/fonc.2023.1175958 |
Ejemplares similares
-
Transdermal Delivery of siRNA through Microneedle Array
por: Deng, Yan, et al.
Publicado: (2016) -
Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010) -
HPV16 Oncoproteins Promote Cervical Cancer Invasiveness by Upregulating Specific Matrix Metalloproteinases
por: Kaewprag, Jittranan, et al.
Publicado: (2013) -
Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine
por: Levine, Rachel M., et al.
Publicado: (2016) -
IRF-1 Inhibits Angiogenic Activity of HPV16 E6 Oncoprotein in Cervical Cancer
por: Rho, Seung Bae, et al.
Publicado: (2020)